Tempus AI, Inc.

Tempus AI, Inc. is a healthcare technology company specializing in the integration of artificial intelligence with clinical, molecular, and genomic data to advance precision medicine. Founded in 2015 and headquartered in Chicago, it was created to address the growing demand for data-driven healthcare solutions, particularly in the fields of oncology, cardiology, radiology, neurology, psychiatry, and dermatology. The company offers a range of products and services—including next-generation sequencing diagnostics, PCR profiling, molecular testing, and platforms such as Hub, One, Lens, and Insights—that streamline diagnostic processes and facilitate drug discovery and development for healthcare providers, pharmaceutical firms, and researchers. Tempus AI operates a global business across more than 30 countries, and collaborates with major partners to develop innovative approaches in personalized medicine. Its rapid expansion is marked by strategic acquisitions, key industry partnerships, and the construction of specialized clinical and pathology laboratories, underscoring its significant role in transforming how medical data informs patient care and research advancements.